TY - CHAP M1 - Book, Section TI - Dihydropyrimidine Dehydrogenase Deficiency A1 - Bissonnette, Bruno A1 - Luginbuehl, Igor A1 - Engelhardt, Thomas PY - 2019 T2 - Syndromes: Rapid Recognition and Perioperative Implications, 2e AB - Genetic disorder with a high phenotypic variability ranging from asymptomatic to developmental delay and seizures. There is an increased life-threatening toxicity when the patient receives 5-fluorouracil, a chemotherapeutic agent for the treatment of cancer. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1164068096 ER -